| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cancer statistics, 1999.
|
CA Cancer J Clin
|
1999
|
9.18
|
|
2
|
Global cancer statistics.
|
CA Cancer J Clin
|
1999
|
8.82
|
|
3
|
Cyclooxygenases 1 and 2.
|
Annu Rev Pharmacol Toxicol
|
1998
|
7.22
|
|
4
|
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.
|
Science
|
1998
|
6.50
|
|
5
|
Direct transesterification of all classes of lipids in a one-step reaction.
|
J Lipid Res
|
1986
|
6.42
|
|
6
|
Role of the insulin-like growth factor family in cancer development and progression.
|
J Natl Cancer Inst
|
2000
|
5.77
|
|
7
|
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.
|
Proc Natl Acad Sci U S A
|
1997
|
4.84
|
|
8
|
Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada.
|
J Natl Cancer Inst
|
1995
|
3.67
|
|
9
|
A prospective study of dietary fat and risk of prostate cancer.
|
J Natl Cancer Inst
|
1993
|
3.40
|
|
10
|
Polyunsaturated fatty acids in the food chain in the United States.
|
Am J Clin Nutr
|
2000
|
3.34
|
|
11
|
Nutritional regulation of the insulin-like growth factors.
|
Endocr Rev
|
1994
|
3.18
|
|
12
|
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County.
|
Br J Cancer
|
1991
|
3.14
|
|
13
|
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.
|
J Natl Cancer Inst
|
1998
|
3.10
|
|
14
|
Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet.
|
J Natl Cancer Inst
|
1995
|
2.70
|
|
15
|
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.
|
J Natl Cancer Inst
|
1998
|
2.67
|
|
16
|
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.
|
J Cell Physiol
|
2000
|
2.47
|
|
17
|
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
|
Cancer Res
|
1997
|
2.34
|
|
18
|
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study.
|
Cancer Res
|
1990
|
2.21
|
|
19
|
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma.
|
Prostate
|
2000
|
2.19
|
|
20
|
A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.
|
Cancer Res
|
1989
|
2.18
|
|
21
|
Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression.
|
J Natl Cancer Inst
|
1999
|
2.04
|
|
22
|
Perspectives for cancer prevention with natural compounds.
|
J Clin Oncol
|
2009
|
1.99
|
|
23
|
Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate.
|
Urology
|
2000
|
1.71
|
|
24
|
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
|
Br J Cancer
|
1997
|
1.69
|
|
25
|
Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
1996
|
1.64
|
|
26
|
Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer.
|
J Natl Cancer Inst
|
1997
|
1.62
|
|
27
|
Diet and prostatic cancer: a case-control study in Hawaii.
|
Am J Epidemiol
|
1988
|
1.60
|
|
28
|
Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study.
|
Br J Cancer
|
1999
|
1.58
|
|
29
|
Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants.
|
J Urol
|
1999
|
1.58
|
|
30
|
Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.
|
Cancer Causes Control
|
1991
|
1.55
|
|
31
|
Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.
|
FASEB J
|
1997
|
1.50
|
|
32
|
Expression of cyclooxygenase-2 in prostate carcinoma.
|
Cancer
|
2000
|
1.49
|
|
33
|
The Victorian Nutrition Survey--intakes and sources of dietary fats and cholesterol in the Victorian population.
|
Med J Aust
|
1988
|
1.47
|
|
34
|
The epidemiology of prostatic cancer. Geographical distribution and time-trends.
|
Acta Oncol
|
1991
|
1.45
|
|
35
|
Growth hormone in obesity.
|
Int J Obes Relat Metab Disord
|
1999
|
1.43
|
|
36
|
Non-steroidal anti-inflammatory drugs and prostate cancer progression.
|
Int J Cancer
|
1998
|
1.43
|
|
37
|
The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
|
Cancer Res
|
1999
|
1.42
|
|
38
|
Epidemiological study of prostatic cancer by matched-pair analysis.
|
Prostate
|
1985
|
1.40
|
|
39
|
Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
|
Int J Obes Relat Metab Disord
|
1997
|
1.40
|
|
40
|
Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid.
|
Prostaglandins Med
|
1979
|
1.33
|
|
41
|
Comparative epidemiology of cancer between the United States and Japan. A second look.
|
Cancer
|
1991
|
1.30
|
|
42
|
Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines.
|
Prostate
|
1991
|
1.24
|
|
43
|
Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.
|
Cancer
|
1999
|
1.19
|
|
44
|
Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells.
|
Br J Cancer
|
1997
|
1.16
|
|
45
|
Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines.
|
Prostate
|
1993
|
1.12
|
|
46
|
Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites.
|
Cancer
|
1994
|
1.07
|
|
47
|
Eicosanoids in neoplasia.
|
Prev Med
|
1987
|
1.01
|
|
48
|
Cellular actions of insulin-like growth factor binding proteins.
|
Horm Metab Res
|
1999
|
1.00
|
|
49
|
Polyunsaturated fatty acids in the food chain in Japan.
|
Am J Clin Nutr
|
2000
|
1.00
|
|
50
|
Insulin-like growth factor-binding protein-1 and prostate cancer.
|
J Natl Cancer Inst
|
1999
|
0.99
|
|
51
|
Trends in diet-related cancers in Japan: a conundrum?
|
Lancet
|
1993
|
0.95
|
|
52
|
The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
|
Anticancer Res
|
1996
|
0.94
|
|
53
|
Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates.
|
Environ Health Perspect
|
1990
|
0.94
|
|
54
|
Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity.
|
J Clin Endocrinol Metab
|
1997
|
0.93
|
|
55
|
Latent prostatic carcinoma: pathological and epidemiological aspects.
|
Jpn J Clin Oncol
|
1989
|
0.93
|
|
56
|
Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice.
|
Carcinogenesis
|
1988
|
0.88
|
|
57
|
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins.
|
Am J Reprod Immunol Microbiol
|
1985
|
0.87
|
|
58
|
Dietary fat and prostate cancer progression and survival.
|
Eur Urol
|
1999
|
0.84
|
|
59
|
Membrane glycoprotein differences between normal lactating mammary tissue and the R3230 AC mammary tumor.
|
Cancer Res
|
1975
|
0.84
|
|
60
|
Dietary essential fatty acids and in vivo prostaglandin production in mammals.
|
World Rev Nutr Diet
|
1983
|
0.84
|
|
61
|
Relative risk of malignant tumors in analgesic abusers. Effects of long-term intake of aspirin.
|
Clin Nephrol
|
1999
|
0.84
|
|
62
|
Prostaglandin modulation of prostate tumor growth and metastases.
|
Anticancer Res
|
1986
|
0.82
|
|
63
|
Dietary fat, fatty acids and prostate cancer.
|
Lipids
|
1992
|
0.80
|
|
64
|
Serum n-3 fatty acids, fish consumption and cancer mortality in six Japanese populations in Japan and Brazil.
|
Jpn J Cancer Res
|
1999
|
0.78
|
|
65
|
Bridging animal and human studies: what are the missing segments in dietary fat and prostate cancer?
|
Am J Clin Nutr
|
1997
|
0.78
|
|
66
|
A role of estrogens and insulin binding in the dietary lipid alteration of R3230AC mammary carcinoma growth in rats.
|
Cancer Res
|
1985
|
0.78
|
|
67
|
Insulin-like growth factor bioactivity and its modification in growth hormone resistant states.
|
Baillieres Clin Endocrinol Metab
|
1996
|
0.76
|
|
68
|
Ten years experience with chronic prostatitis in Africans.
|
East Afr Med J
|
1996
|
0.75
|
|
69
|
Prostaglandins and cancer.
|
Ann Clin Lab Sci
|
1983
|
0.75
|
|
70
|
Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.
|
Cancer Res
|
1987
|
0.75
|